Farzin Haque
Stock Analyst at Jefferies
(2.92)
# 1,434
Out of 5,150 analysts
4
Total ratings
75%
Success rate
69.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $4.77 | +88.68% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $4.74 | +110.97% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.49 | +571.14% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $39.65 | -34.43% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $4.77
Upside: +88.68%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.74
Upside: +110.97%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $39.65
Upside: -34.43%